A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022
Sign Up to like & getrecommendations! Published in 2023 at "Eurosurveillance"
DOI: 10.2807/1560-7917.es.2023.28.15.2200746
Abstract: Background To cope with the persistence of the COVID-19 epidemic and the decrease in antibody levels following vaccination, a third dose of vaccine has been recommended in the general population. However, several vaccine regimens had… read more here.
Keywords: vaccination; immunogenicity; vaccine regimens; vaccine dose ... See more keywords
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2017.00595
Abstract: A key aspect to finding an efficacious human immunodeficiency virus (HIV) vaccine is the optimization of vaccine schedules that can mediate the efficient maturation of protective immune responses. In the present study, we investigated the… read more here.
Keywords: human immunodeficiency; prime boost; vaccine regimens; immunodeficiency virus ... See more keywords